Skip to main content

Want a detailed portfolio tracker?

BIAF
NASDAQ
$0.70

BioAffinity Technologies Inc (BIAF)

bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.

This company is also listed under the following tickerBIAFW.

Website: https://bioaffinitytech.com
Target: $6 (+758.49%)

Market Cap

$3.25M

Beta (5Y)

1.85

Price Chart

Valuation
Market Cap$3.25M
P/S0.80
P/B1.22
Profitability
Total Revenue (TTM)$5.66M
Gross Profit (TTM)$1.87M
EBITDA-$11M
Profit Margin-280.6%
Operating Margin-267.6%
EPS-$7.25
Growth & Risk
Beta (5Y)1.85
Sharpe Ratio-0.59